Journal of the American Chemical Society · 2009 · 79 citations · 26 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular OncologyMolecular PharmacologyCancer MetabolismCellular Responses To HypoxiaHypoxia AdaptationSignal Transduction In CancerTargeted Cancer TherapyTumor Microenvironment ModulationHif-1 Alpha RegulationHif-1 SignalingHypoxia Response GenesHypoxia-inducible Factor RegulationHypoxia-inducible Factor SignalingHypoxia-inducible RegulationHypoxia-inducible SignalingTumor Microenvironment Hypoxia
Selective blockade of hypoxia-inducible gene expression by designed small molecules would prove valuable in suppressing tumor angiogenesis, metastasis and altered energy metabolism. We report the design, synthesis, and biological evaluation of a dimeric epidithiodiketopiperazine (ETP) small molecule transcriptional antagonist targeting the interaction of the p300/CBP coactivator with the transcription factor HIF-1alpha. Our results indicate that disrupting this interaction results in rapid downregulation of hypoxia-inducible genes critical for cancer progression. The observed effects are compound-specific and dose-dependent. Controlling gene expression with designed small molecules targeting the transcription factor-coactivator interface may represent a new approach for arresting tumor growth.
26
Lysyl oxidase is essential for hypoxia-induced metastasis
Janine T. Erler, Kevin L. Bennewith, Monica Nicolau et al. · Nature · 2006 · 1.3K citations
Medicine, Cancer Biology, Oncology +14
Suppression of tumor growth through disruption of hypoxia-inducible transcription
Andrew L. Kung, Stream Wang, Jeffery M. Klco et al. · Nature Medicine · 2000 · 499 citations
Medicine, Cancer Biology, Oncology +14